Prevalence of Streptococcus pyogenes and methisillin-resistant Staphylococcus aureus in the pharynx of healthy children in the town of Gardabaer;Algengi Streptococcus pyogenes og methisillín ónæmra Staphylococcus aureus í hálsi heilbrigǒra barna í Garǒabæ

Laeknabladid

Volumn 94, Issue 6, 2008, Pages 447-451

  Magnúsdóttir, Björg Puríǒur ^a   Jónsson, Jón Steinar ^a   Kristinsson, Karl G ^a  

^a Efra Breiǒholti ^*

Author keywords

Carrier; Methicillin resistant Staphylococcus Aureus; Pharyngitis; Streptococcus pyogenes

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HETEROZYGOTE; HUMAN; ICELAND; ISOLATION AND PURIFICATION; MICROBIOLOGY; PENICILLIN RESISTANCE; PHARYNGITIS; PHARYNX; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CROSS-SECTIONAL STUDIES; HUMANS; ICELAND; METHICILLIN RESISTANCE; PHARYNGITIS; PHARYNX; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 49249102668     PISSN: 00237213     EISSN: 16704959     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bisno AL. Acute pharyngitis: etiology and diagnosis. Pediatrics 1996; 97: 949.
2. Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child 1972; 124: 352.
3. Landlæknisembættǐ. Klínískar leǐbeiningar um hálsbólgu, 2004.
4. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. CID 2002; 35: 113-125
5. Ozturk CE, Yavuz T, Kaya D, Yucel M. The rate of asymptomatic throat carriage of group A streptococcus in school children and associated ASO titers in Duzce, Turkey. Jpn J Infect Dis 2004; 57: 271-272
6. Gunnarsson RK, Holm SE, Söderström M. The prevalence of beta-haemolytic streptococci in throat specimens from healthy children and adults. Scand J Prim Health Care 1997; 15: 149-155
7. Strömberg A, Schwan A, Cars O. Throat carrier rates of betahemolytic streptococci among healthy adults and children. Scand J Infect Dis 1988; 20: 411-417
8. Hoffmann S. The throat carrier rate of group A and other beta hemolytic streptococci among patients in general practice. Acta Path Microbiol Immunol Scand 1985; 93: 347-351
9. Begovac J, Bobinac E, Benic B, et al. Asymptomatic pharyngeal carriage of beta-haemolytic streptococci and streptococcal pharyngitis among patients at an urban hospital in Croatia. Eur J Epidemiol 1993; 9: 405-410
10. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325:783-793
11. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard. Clinical and Laboratory Standards Institute document M2-A9 ninth ed: Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-21898 USA; 2006.
12. Pichichero ME, Marsocci SM, Murphy ML, Hoeger W, Green JL, Sorrento A. Incidence of streptococcal carriers in private pediatric practice. Arch Pediatr Adolesc Med 1999; 153: 624-628
13. Gerber MA. Comparison of throat cultures and rapid strep test for diagnosis of streptococcal pharyngitis. Pediatr Infect Dis J 1989; 8: 820-824
14. Landlæknir. Skráningarskyldir sjúkdómar eftir mánǔum, 1997-2006.
15. Cornfeld D, Hubbard JP, Harris TN, Weaver R. Epidemiologic studies of streptococcal infection in school children. Amer J Publ Health 1961; 51: 242-249
16. James WE, Badger GF, Dingle JH. A study of illnesses in a group of Cleveland families, XIX; the epidemiology of the acquisition of group A streptococci and of associated illness. N Engl J Med 1960; 262: 687-694
17. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med. 1981; 98: 326-335
18. Roos K, Holm SE, Grahn E, Lind L. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: A randomized placebo-controlled study. Scand J Infect Dis 1993; 25: 31.
19. Gerber MA, Tanz RR, Kabat W, et al. Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 1999; 104: 911-917
20. Tagg JR. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Indian J Med Res 2004; 119 Suppl: 13-16
21. Baquero F, Garcia-Rodriguez JA, de Lomas JG, Aguilar L. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study. Antimirob Agents Chemother 1999; 43: 178-180
22. Ringberg H, Petersson AC, Walder M, Johansson PJH. The throat: An important site for MRSA colonization. Scand J Infect Dis 2006; 38: 888-893.